Ildong Pharmaceutical Exports Raw Materials for Hypertension Treatment to China

Ildong Pharmaceutical announced on the 22nd that it has decided to export the cardiovascular active pharmaceutical ingredient (API) ‘Benidipine Hydrochloride’ to Tosun Pharmaceutical in Guangzhou, China.

Ildong Pharmaceutical Headquarters Exterior [Photo by Ildong Pharmaceutical]

Benidipine is a calcium channel blocker (CCB) drug that blocks the pathways for calcium ion movement involved in the contraction of blood vessels and heart muscles, thereby dilating blood vessels and reducing the burden on the heart. It is mainly used for treating hypertension and angina.

The company explained that it recently signed a partnership agreement with Tosun regarding the supply of Benidipine and is currently proceeding with the necessary procedures for local entry into the Chinese market. Previously, Ildong Pharmaceutical also obtained registration and approval for the Benidipine API from the Chinese pharmaceutical regulatory authorities.

Tosun is a pharmaceutical company specializing in pharmaceutical raw materials and intermediates located in Guangzhou, China. It has secured over 1,500 clients worldwide and possesses a broad network of approximately 500 business partners and a solid distribution network.

According to the contract, Ildong Pharmaceutical will supply Benidipine Hydrochloride produced by itself to Tosun, and Tosun will carry out API distribution and sales, as well as local marketing targeting the pharmaceutical market and related companies within China.

An official from Ildong Pharmaceutical stated, “Ildong Pharmaceutical’s Benidipine API is synthesized and manufactured using proprietary technology and has been recognized for its excellence to the extent that it is exported to countries such as Japan,” adding, “As the number of cardiovascular patients in China continues to increase steadily, the demand for treatments and the related market have great growth potential. We plan to focus our efforts on pioneering the Chinese market by expanding our business scope based on this contract.”

This content was produced with the assistance of AI translation services.